Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-18-058304

Options or other derivatives

  • Director acquired 203,851 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

HILZINGER KURT J · Director

Table II: Derivative

1 line
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2018-11-09 Grant or award : show line 1 in the form Stock Option (Right to Buy) +203,851 $0.61 $124,961 $0.89 2028-11-09 203,851 203,851 D
Loading xslF345X03/doc4.xml…